McIntyre Lauralyn A, Hebert Paul C
Department of Medicine, Division of Critical Care, Centre for Transfusion and Critical Care Research, Ottawa Health Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada.
Curr Opin Crit Care. 2006 Dec;12(6):575-83. doi: 10.1097/MCC.0b013e32801067f0.
Transfusion of red blood cells in the trauma patient can be lifesaving. The question is how much and when? It is important to weigh the risks and benefits of red blood cell transfusions, as well alternatives to transfusion as these products are not benign.
We explore the evidence, and provide the rationale for current and future red blood cell transfusion strategies within a framework of prehospital and hospital care of the trauma patient. We also describe how red blood cell transfusion trends are changing in trauma, discuss alternatives to red blood cell transfusion and present evidence from randomized controlled trials that support a lower transfusion trigger.
Optimal transfusion practice and use of alternatives in trauma is a rapidly expanding and important area of research. Strong clinical evidence derived by future randomized controlled trials in the area of transfusion triggers as well as transfusion alternatives is required to determine their roles in clinical practice.
对创伤患者输注红细胞可能挽救生命。问题在于输注多少以及何时输注?权衡红细胞输注的风险和益处很重要,因为这些产品并非无害,同时也要考虑输血的替代方法。
我们探讨了相关证据,并在创伤患者院前和院内护理的框架内,为当前和未来的红细胞输血策略提供了理论依据。我们还描述了创伤中红细胞输血趋势的变化,讨论了红细胞输血的替代方法,并展示了支持较低输血阈值的随机对照试验证据。
创伤中最佳的输血实践和替代方法的使用是一个迅速发展且重要的研究领域。需要未来在输血阈值以及输血替代方法领域进行的随机对照试验得出有力的临床证据,以确定它们在临床实践中的作用。